INSIGHTS ON CLINICAL TRIAL DESIGN

• Ensuring A Diverse Patient Population In Clinical Trials

  In 2025, the FDA will require pharmaceutical companies to include diversity action plans (DAPs) for Phase II and pivotal studies.

• The True Science Behind eCOA, Shaped By Patient And Site Insights

   

  This webinar brings together patients, sites, and eCOA science to dismantle the researcher-subject hierarchy and replace it with a collaborative model.

   

• Everything You Need To Know About Mobile Visits And Community Sites

  Discover how decentralized clinical trials (DCTs) and mobile visits contribute to more diverse, efficient, and patient-centric research, ultimately enhancing trial outcomes and data quality.

• Improving Patient Access Through Home-Based Trials, Site Networks

  By implementing home trial support, sponsors can improve patient access, enhance diversity, and ultimately accelerate the development of new therapies.

• Clinical Trial Design Strategies To Improve Patient Retention

  5/27/2025

  While clinical trial planning often emphasizes rapid enrollment, sustained patient retention is equally vital to success.

• Smarter, More Accurate Patient Matching Enhances Trial Efficiency

  5/20/2025

  Even when patient recruitment criteria grows complex, this direct-to-data approach can pinpoint precise patients needed and provide an alert to your team when they are found.

• Completed Clinical Trials Continued To Climb In 2024

  6/19/2025

  Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.

• Korio RTSM Platform: Real-Time Audit Trail Demo

  3/18/2026

  Watch a real-time walkthrough of Korio’s built-in audit trail. Human-readable, blind-controlled, and fully exportable—see how sponsors get instant access to critical trial data.

• Navigating The Complexities Of Cross-Border Clinical Trials

  4/28/2025

  Explore the regulatory, logistical, and patient-centered challenges of cross-border clinical trials, including insights on enhancing collaboration and prioritizing patients in global research.